Rich countries have held enough coronavirus vaccines to protect their populations nearly three times over by the end of 2021, Amnesty International and other groups said on Wednesday, probably depriving billions of people in poorer areas.
Britain approved Pfizer’s COVID-19 vaccine this month, and has raised hopes that the tide could soon turn against a virus that has claimed nearly 1.5 million globally, hammered the world economy and upended normal life.
Amnesty and other organisations including Frontline AIDS, Global Justice Now and Oxfam, urged governments and the pharmaceutical industry to take action to ensure intellectual property of vaccines is shared widely.
ALSO READ| COVID Vaccine In India: Who Will Get It First And How Much Will It Cost?
Moreover, the World Health Organization (WHO) has also called on governments repeatedly this year to make a vaccine protecting against COVID-19 a “public good”.
The WHO has backed a global vaccine programme scheme known as COVAX, which looks to ensure equitable distribution of vaccines and 189 countries have joined the programme. But some countries such as the United States have not signed up, even after securing the bilateral deals.
By the end of 2021, COVAX hopes to deliver some 2 billion doses but that would still only represent about 20% of the populations of countries that are part of the mechanism.
“Nearly 70 poor countries will only be able to vaccinate one in ten people against COVID-19 next year unless urgent action is taken,” Amnesty International said, based on recent calculations.
ALSO READ| Covid Shots: Will Rich Countries Monopolize Supply?
“Updated data shows that rich nations representing just 14% of the world’s population have bought up 53% of all the most promising vaccines so far,” it said.
Amnesty said Canada was the country that had bought the most shots when considering the size of its population with enough doses to vaccinate every Canadian five times.
The organisation asked for support for a proposal made by South Africa and India to the World Trade Organisation Council to waive intellectual property rights for COVID-19 vaccines, tests and treatments.